Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Cytokine-driven glycosphingolipid metabolism modulates endoplasmic reticulum calcium homeostasis in primary human renal mesangial cells

Provisionally accepted
Tamara  K. NowlingTamara K. Nowling*Mariia  StefanenkoMariia StefanenkoTessa  M. OrtizTessa M. OrtizSandra  G. MungaraySandra G. MungarayMykhailo  FedoriukMykhailo FedoriukOleg  PalyginOleg PalyginStefano  BertoStefano BertoDrew  MooreDrew Moore
  • Medical University of South Carolina, Charleston, United States

The final, formatted version of the article will be published soon.

Glycosphingolipids (GSLs), including hexosylceramides (HexCers), lactosylceramides (LacCers), and gangliosides composed of one or more sugar residues attached to ceramide, are essential components of cell membranes. Dysregulated GSL metabolism has been implicated in various inflammatory and autoimmune diseases, including lupus nephritis; however, its contribution to renal cell dysfunction remains largely unexplored. In this study, we demonstrate that in primary human renal mesangial cells (hRMCs), proinflammatory cytokines relevant to lupus elicit significant upregulation and secretion of inflammatory mediators that parallel intracellular and extracellular accumulation of HexCers and elevated cytosolic calcium (Ca2+) levels. The increase in cytosolic Ca2+ was attributed to a decrease in endoplasmic reticulum (ER) Ca2+ store capacity. Pharmacological inhibition of GSL synthesis with eliglustat significantly reduced HexCers levels and restored ER Ca2+ stores, but did not impact cytokine-induced cytokine/chemokine secretion or cell viability/proliferation. Together, these data suggest that elevated GSL synthesis modulates cytokine-induced ER Ca²⁺ dysregulation in mesangial cells and may play a role in the pathogenesis of lupus nephritis.

Keywords: Mesangial cell, Endoplasmic reticulum stress, Glycosphingolipid, Cytokines, lupus

Received: 19 Aug 2025; Accepted: 12 Nov 2025.

Copyright: © 2025 Nowling, Stefanenko, Ortiz, Mungaray, Fedoriuk, Palygin, Berto and Moore. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tamara K. Nowling, nowling@musc.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.